RxSight, Inc. (RXST)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Ilya Goldshleger Ph.D.
|
Chief Operating Officer | 634.01k | 112.3k | 1975 |
|
Mr. Eric J. Weinberg
|
Chief Business Development Officer | 2.75M | 2.18M | 1961 |
|
Dr. Ronald M. Kurtz M.D.
|
Chief Medical Officer | 834.13k | -- | 1963 |
|
Mr. Mark Wilterding
|
Chief Financial Officer | -- | -- | 1978 |
|
Mr. Oliver Moravcevic
|
Vice President of Investor Relations | -- | -- | -- |
|
Mr. Jim Schindler
|
Executive VP & General Counsel | -- | -- | -- |
RxSight, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 461
Description
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Corporate Governance
Upcoming Events
November 3, 2026 at 8:00 PM UTC
RxSight, Inc. Earnings Date
Recent Events
May 29, 2026 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
